ProKidney Corp. (PROK)
$1.70 $0.16 (9.97%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.81B -
Day's Range
$1.54 - $1.74 -
Volume
1,607,061 -
52 Week Low / High
$1.12 - $4.85 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
PROK's Dividend
Analyists Ranking
- 4
- Strong Buy
- 0
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $15.33
- Target Price
Company News
-
ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S. — Sep 3rd, 2024
ProKidney Refined the focus of the Phase 3 program to accelerate path to potential U.S. approval and commercial launch in the Company’s highest priority market Discontinued the ex-U.S.-based PROACT 2 trial and focused Company resources on PROACT 1 to expedite enrollment and accelerate ...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$